Vancouver, British Columbia (FSCwire) - LED Medical Diagnostics Inc. ("LED" or the "Company") (TSX-V: LMD) has announced that it will be participating at the sixth annual Bloom Burton & Co. Healthcare Investor Conference on May 1 and 2, 2017 at the Sheraton Centre Toronto Hotel. Bloom Burton & Co. will be showcasing approximately sixty of the premier Canadian healthcare companies, including LED, to its network of investors from across Canada, the U.S. and Europe. Investors will have the opportunity to obtain a corporate update and meet LED management.

In light of LED's recent acquisition of and combination with Apteryx Inc., a highly accretive transaction along with a significant equity financing with institutional investors, LED also announced that it has granted a total of 28,550,000 stock options exercisable at a range of CDN$0.09 to CDN$0.10 per share to directors, officers, consultants and employees, including employees of its recently acquired subsidiary Apteryx Inc. and its existing subsidiaries LED Dental Inc. and LED Dental Ltd., all in accordance with its stock option plan and in order to incentivize the team for future growth in respect of the new capitalization. The options are for a term of up to 5 years and generally vest over a three-year period. The total options granted represent less than 10% of LED's shares outstanding.

About Apteryx, Inc.

Apteryx, Inc. was founded in 1995 to create and develop software applications and systems that are leading products in their respective industry segments. Apteryx's products include the XrayVision product line, an imaging suite of applications that digitize x-rays and other images for dental practitioners; the XrayVision DCV product line, a DICOM-based client software and PACS for the institutional dental market; XVWeb, a cloud-based PACS and DICOM server; and other Windows-based applications and utilities. For additional information visit the Apteryx web site at www.apteryx.com

About LED Medical Diagnostics Inc.

Founded in 2003 and headquartered in Vancouver, British Columbia, Canada, LED Medical Diagnostics Inc., through its wholly-owned subsidiaries LED Dental Inc. and LED Dental Ltd., provide dentists and oral health specialists with advanced diagnostic imaging products and software, in addition to the award-winning VELscope (R) Vx tissue fluorescence visualization technology. Backed by an experienced leadership team and dedicated to a higher level of service and support, LED Dental is committed to providing dental practitioners with the best technology available by identifying and adding leading products to its growing portfolio.

The Company is currently listed on the TSX-V under the symbol "LMD", the OTCQB under the symbol "LEDIF", as well as the Frankfurt Stock Exchange under the symbol "LME".For more information, call 884.952.7327 or visit www.leddental.com/investor-relations.

LED Medical Diagnostics

Corporate Contact:

LED Medical

David Gane, CEO

Phone: 604-434-4614 x227

Email: david.gane@leddental.com

Investor Relations:

Glen Akselrod
Phone: 905.326.1888 ext 10

Email: glen@bristolir.com

Media Contact:

LED Dental

Chris Koch

Phone: 678.293.9413

Email: chris.koch@leddental.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view this press release as a PDF file, click onto the following link:
public://news_release_pdf/ledmedical04102017.pdf

Source: LED Medical Diagnostics Inc. (TSX Venture:LMD, OTCQX:LEDIF, FWB:LME)

To follow LED Medical Diagnostics Inc. on your favorite social media platform or financial websites, please click on the icons below.

Maximum News Dissemination by FSCwire. http://www.fscwire.com

Copyright (C) 2017 Filing Services Canada Inc.